Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 18/20 | 0.46 |
| ▸ | TACR2 | P21452 | 12/20 | 0.46 |
| ▸ | TACR1 | P25103 | 10/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3815133 | 0.91 | TACR3 (0.48) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3815625 | 0.90 | TACR3 (0.44) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3815823 | 0.89 | TACR3 (0.42) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3812475 | 0.87 | TACR3 (0.46) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3810312 | 0.86 | TACR3 (0.51) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3820836 | 0.86 | P2RX7 (0.47) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3814056 | 0.86 | TACR3 (0.46) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3812683 | 0.86 | TACR3 (0.47) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL928665 | 0.85 | GRM5 (0.44) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3818140 | 0.84 | TACR3 (0.51) | TACR3TACR2TACR1KCNH2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | claimed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009095253-A1 | 6-HALO-PYRAZOLO[1, 5-A]PYRIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR (MGLUR) MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-08-06 | — | — | WO | disclosed |